Hasan Kocaayan on Association of High BMI and VTE in ANCA-Vasculitis
Hasan Kocaayan, Rheumatology Resident at Izmir Katip Celebi University, reposted from TRVaS Turkish Vasculitis Study Group on LinkedIn:
”Our new study reflecting the real-life experience of TRVaS (Turkish Vasculitis Study Group) has just been published:
Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TRVaS Experience”
Qutoing TRVaS Turkish Vasculitis Study Group‘s post:
”We are delighted to share some great news!
Our new study reflecting the real-life experience of TRVaS (Turkish Vasculitis Study Group) has just been published:
Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TRVaS Experience
This study highlights that venous thromboembolism risk may be increased during the early phases of ANCA-associated vasculitis (AAV) and may be associated with a higher body mass index.
We believe these findings will contribute meaningfully to clinical awareness and patient management in vasculitis.
Access the article here.
We sincerely thank all collaborators and members of the TRVaS network for their valuable contributions.
We are truly happy and proud!
Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TRVaS Experience
This study demonstrates that the risk of venous thromboembolism may be increased in patients with ANCA-associated vasculitis (AAV), particularly in the early stages of the disease, and suggests a possible association with a high body mass index.
We believe that these data, obtained in collaboration with TRVaS, will make important contributions to clinical awareness and patient management.”
Read the full article here.
Article: Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR-VaS Experience
Authors: Hasan Kocaayan, Elif Durak Ediboglu, Tuba Demirci Yıldırım, Bahar Ozdemir Ulusoy, Tahir Saygin Ogut, Busra Firlatan, Duygu Sevinc Ozgur et al.
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism